pRRL_U2AF1_WT_mCherry Citations (2)
Originally described in: U2AF1 mutations alter splice site recognition in hematological malignancies.Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK Genome Res. 2015 Jan;25(1):14-26. doi: 10.1101/gr.181016.114. Epub 2014 Sep 29. PubMed Journal
Articles Citing pRRL_U2AF1_WT_mCherry
| Articles |
|---|
| GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignancies. Benbarche S, Pineda JMB, Galvis LB, Biswas J, Liu B, Wang E, Zhang Q, Hogg SJ, Lyttle K, Dahi A, Lewis AM, Sarchi M, Rahman J, Fox N, Ai Y, Mehta S, Garippa R, Ortiz-Pacheco J, Li Z, Monetti M, Stanley RF, Doulatov S, Bradley RK, Abdel-Wahab O. Mol Cell. 2024 May 16;84(10):1886-1903.e10. doi: 10.1016/j.molcel.2024.04.006. Epub 2024 Apr 29. PubMed |
| CRL3(ARMC5) ubiquitin ligase and Integrator phosphatase form parallel mechanisms to control early stages of RNA Pol II transcription. Cacioppo R, Gillis A, Shlamovitz I, Zeller A, Castiblanco D, Crisp A, Haworth B, Arabiotorre A, Abyaneh P, Bao Y, Sale JE, Berry S, Tufegdzic Vidakovic A. Mol Cell. 2024 Dec 19;84(24):4808-4823.e13. doi: 10.1016/j.molcel.2024.11.024. Epub 2024 Dec 11. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.